When a room full of founders and investors feels like the future, you know you’re in the right place. That was the atmosphere at the The Ventures Award Poland 2025 finale held in early September at Google for Startups Campus in Warsaw. The Ventures is a travelling competition that seeks out young companies with the potential to scale globally. In every city, from Miami to Tokyo, the format is the same: startups pitch in front of a hand‑picked jury drawn from venture funds and corporate innovation teams, and the best are recognised across four categories: Best Product, Best Team, Best Traction and Best AI Model. The winners gain bragging rights, deep connections to investors, and global publicity.
This year’s Polish edition was a celebration of daring ideas. Applications were open to ventures at the pre‑seed to Series A stage and across any sector as long as they could get to Warsaw for the finals. Dozens of companies representing Web3, FinTech, HealthTech and SportsTech made the shortlist, and on the night, four stood out. The Best AI Model accolade went to BloodGPT, an AI‑driven health platform that turns opaque lab reports into clear insights. Other winners included Vitaflow for Best Product, Midcontract for Best Team, and Talefy for Best Traction, recognising that Poland’s start-up scene is not just vibrant but diverse, spanning deep tech healthcare, B2B workflow automation, and consumer storytelling.
Why BloodGPT Stood Out
Blood tests are a mainstay of modern medicine, yet interpreting them isn’t easy. Hospitals and clinics generate millions of lab reports every day, and physicians spend hours turning cryptic numbers into actionable advice. The founders of BloodGPT, biochemist Nikita Udovichenko and AI entrepreneur Vasilii Lazuka, saw that gap and built a product to close it. Their platform uses a multi‑agent AI architecture rather than a generic large language model; this design choice was intentional because a 5% error rate is unacceptable in healthcare. BloodGPT interprets any blood test in seconds across 98 languages, analyses trends over time, and gives clinicians the ability to review and approve recommendations.
What impressed the judges was not only the technology but also the traction. BloodGPT already has over 500 paying subscribers on its consumer product and is preparing to launch a B2B version for hospitals and clinics. The system reduces a doctor’s administrative burden from four to seven hours per week to half an hour or less, freeing physicians to focus on care. For patients, it turns confusing PDFs into personalised dashboards with simple explanations and trend visualisations. This combination of user‑centric design, clinical rigour and market adoption made BloodGPT a natural choice for the Best AI Model award.
The Ventures’ Global Vision
The Ventures Award is not just a competition; it’s part of a global circuit aimed at connecting early‑stage founders with capital and mentors. According to the organisation’s official site, finalists get to pitch in front of a jury comprised of partners from venture capital funds, accelerators and corporate innovation teams. Benefits for participants include hands‑on advice on scaling, exposure in top tech capitals, and a chance to forge relationships with other entrepreneurs. The structure replicates across countries: categories for Best Product, Best Traction, Best Team and Best AI Model ensure that both product excellence and business execution are rewarded.
Looking Ahead
BloodGPT’s win is more than a trophy; it signals a broader shift in how healthcare is embracing AI. The team has already raised $1 million at a $10 million valuation and plans to close the round by June. They are positioning themselves as a trusted clinical tool rather than a flashy gadget, emphasising transparency, regulatory compliance and physician control. As global healthcare systems grapple with clinician burnout and patient demand for personalised care, solutions like BloodGPT could become indispensable.
For Poland’s tech scene, the 2025 edition of The Ventures Award sets a high bar. It showcased fearless founders and reminded us that innovation does not belong to Silicon Valley alone. Whether you’re an investor scouting for the next big thing, a startup founder looking for inspiration, or a clinician curious about AI, keep an eye on BloodGPT and its fellow finalists. Their success hints at a future where AI isn’t just augmenting our decisions; it’s helping us understand ourselves better.
Articles Referenced:
